Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum.
Hamouda
B
B
Jamila
Z
Z
Najet
R
R
Slim
T
T
Rafiaa
N
N
Noureddine
B
B
Ahmed
E M
EM
Mohamed
F
F
Ridha
K M
KM
Abderrahman
L
L
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005145:Face / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D016896:Treatment Outcome; D014983:Xeroderma Pigmentosum / Q000150:complications*
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil